Log In
BCIQ
Print this Print this
 

DecisionDx-Thymoma

  Manage Alerts
Collapse Summary General Information
Company Castle Biosciences Inc.
DescriptionGene expression profile test that measures the activity of 23 genes within a tumor
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect the likelihood of metastasis in thymic cancer; Diagnose thymic carcinoma or thymoma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/30/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today